Cardiac function in hearts isolated from a rat model deficient in mast cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Kennedy, Richard H ^a,c,d,e   Hauer Jensen, Martin ^b   Joseph, Jacob ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Compliance; Diastolic dysfunction; Langendorff perfused hearts

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; CORONARY ARTERY PRESSURE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE COMPLIANCE; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; ISOLATED HEART; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARDIOMEGALY; DIASTOLE; MALE; MAST CELLS; MYOCARDIAL CONTRACTION; RATS; RATS, MUTANT STRAINS; SYSTOLE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 12344299163     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00803.2004     Document Type: Article

References (38)

1. Briest W, Rabler B, Deten A, and Zimmer HG. Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation. Mol Cell Biochem 252: 229-237, 2003.
2. Chancey AL, Brower GL, and Janicki JS. Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am J Physiol Heart Circ Physiol 282: H2152-H2158, 2002.
3. Dai S and Ogle CW. Ventricular histamine concentrations and mast cell counts in the rat heart during acute ischaemia. Agents Actions 29: 138-144, 1990.
4. De Almeida A, Mustin D, Forman MF, Brower GL, Janicki JS, and Carver W. Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression. J Cell Physiol 191: 51-59, 2002.
5. Bewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, Gersch C, Tincey S, Michael LH, Entman ML, and Frangogiannis NG. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 164: 667-677, 2004.
6. Doering CW, Jalil JE, Janicki JS, Pick R, Aghili S, Abrahams C, and Weber KT. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 22: 686-695, 1988.
7. Engels W, Reiters PHCM, Daemen MJAP, Smits JFM, and Van der Vusse GJ. Transmural changes in mast cell density in rat heart after infarct induction in vivo. J Pathol 177: 423-429, 1995.
8. Engels W, Van Haaster CMCJ, Vleeming W, and Van der Vusse GJ. Antigen-evoked mast cell degranulation in isolated rat heart: no effect on subsequent ischemia-reperfusion induced damage. Inflamm Res 46: 40-45, 1997.
9. Frangogiannia NG, Perrard JL, Mendoza LH, Burns AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, and Entman ML. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98: 687-698, 1998.
10. Gilbert J and Glantz S. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res 64: 827-852, 2989.
11. Gilles S, Zahler S, Welsch U, Sommerhoff CP, and Becker BF. Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60: 608-616, 2003.
12. Gruber BL, Marchese MJ, Ko S, Schwartz LB, Okada Y, Nagase H, and Ramamurthy NS. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 84: 1657-1662, 1989.
13. v mice. Biochim Biophys Acta 878: 440-445, 1986.
14. Hara M, Matsumori A, Ono K, Kido H, Hwang MW, Miyamoto T, Iwasaki A, Okada M, Nakatani K, and Sasayama S. Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 100: 1443-1449, 1999.
15. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, and Matsumori A. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195: 375-381, 2002.
16. Harris TS, Baicu CF, Conrad CH, Koide M, Buckley JM, Barnes M, Cooper G, and Zile MR. Constitutive properties of hypertrophied myocardium: cellular contribution to changes in myocardial stiffness. Am J Physiol Heart Circ Physiol 282: H2173-H2182, 2002.
17. Horiguchi K and Komuro T. Ultrastructural cha racterization of interstitial cells of Cajal in the rat small intestine using control and Ws/Ws mutant rats. Cell Tissue Res 293: 277-284, 1998.
18. Joseph J, Washington A, Joseph L, Koehler L, Fink LM, Hauer-Jensen M, and Kennedy RH. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 283: H2567-H2574, 2002.
19. Keller AM, Clancy RM, Barr ML, Marboe CC, and Cannon PJ. Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells. Circ Res 63: 1044-1052, 1988.
20. Liu LWC, Wang XY, Ye J, Tougas G, Perdue MH, and Huizinga JD. Interstitial cell of Cajal-the putative stretch receptor for the activation of the gastric afferent pathway. Can Digest Dis Week. http://www.pulsus.com/ cddw2003/abs/abs067.htm.
21. Marone G, DeCrescenzo G, Patella V, Granata F, Verga L, Arbustini E, and Genovese A. Human heart mast cells: immunological characterization in situ and in vitro. In: Mast Cells and Basophils, edited by Marone G, Lichtenstein LM, and Galli SJ. San Diego, CA: Academic, 2000, p. 455-478.
22. Masini E, Gambassi F, Bianchi S, Mugnai L, Lupini M, Pistelli A, and Mannaioni PF. Effect of nitric oxide generators on ischemia-reperfusion injury and histamine release in isolated perfused guinea pig heart. Int Arch Allergy Appl Immunol 94: 257-258, 1991.
23. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, and Kinoshita M. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 107: 2555-2558, 2003.
24. Morimoto M, Kasugai T, Tei H, Jippo-Kanemoto T, Kanakura Y, and Kitamura Y. Age-dependent amelioration of hypoplastic anemia in Ws/Ws rats with a small deletion at the kinase domain of c-kit. Blood 82: 3315-3320, 1993.
25. Niwa Y, Kasugai T, Ohno K, Morimoto M, Yamazaki M, Dohmae K, Nishimune Y, Kondo K, and Kitamura Y. Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood 78: 1936-1941, 1991.
26. Panizo A, Mindan FJP, Galindo MF, Cenarruzabeitia E, Hernandez M, and Diez J. Are mast cells involved in hypertensive heart disease? J Hypertens 13: 1201-1208, 1995.
27. Parikh V and Singh M. Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 31: 779-785, 1998.
28. Parikh V and Singh M. Possible role of cardiac mast cells in norepinephrine-induced myocardial preconditioning. Methods Find Exp Cin Pharmacol 21: 269-274, 1999.
29. Patella V, Marino I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, and Marone G. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemie cardiomyopathy. Circulation 97: 971-978, 1998.
30. Rakusan K, Sarkar K, Turek Z, and Wicker P. Mast cells in the rat heart during normal growth and in cardiac hypertrophy. Circ Res 66: 511-516, 1990.
31. Saarinen J, Kalkkinen N, Welgus HG, and Kovanen PT. Activation of human interstitial procollagenase through the direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 269: 18134-18140, 1994.
32. Shiota N, Rysa J, Kovanen PT, Ruskoaho H, Kokkonen JO, and Lindstedt KA. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 21: 1935-1944, 2003.
33. Stewart JA Jr, Wei CC, Brower GL, Rynders PE, Hankes GH, Dillon AR, Lucchesi PA, Janicki JS, and Dell'Italia LJ. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 35: 311-319, 2003.
34. Takeshita K, Hayashi M, Iino S, Kondo T, Inden Y, Iwase M, Kojima T, Hirai M, Ito M, Loskutoff DJ, Saito H, Murohara T, and Yamamoto K. Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction. Am J Pathol 164: 449-456, 2004.
35. Tsujimura T, Hirota S, Nomura S, Niwa Y, Yamazaki M, Tono T, Morli E, Kim HM, Kondo K, Nishimune Y, and Kitamura K. Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. Blood 78: 1942-1946, 1991.
36. Van Haaster CMCJ, Engels W, Duijvestijn AM, Lemmens PJMR, Hornstra G, and Van der Vusse GJ. Lack of evidence for a role of mast cell degranulation in acute hypoxia/reoxygenation-induced injury in the isolated rat heart. J Mol Cell Cardiol 28: 363-373, 1996.
37. Wang P, Bowney JM, and Cohen MV. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 91: 458-467, 1996.
38. Zile MR and Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I, diagnosis, prognosis and measurements of diastolic function. Circulation 105: 1387-1393, 2002.